B Hall Strategies, LLC is a registered federal lobbying firm. For Q3 2026 it reported $580K across 21 client reports and lists 1 lobbyist across its filings. Issues include Pharmacy, Medicare/Medicaid and Health Issues.
| Client | Reported | Issues |
|---|---|---|
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA | $50K | Pharmacy |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. | $50K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. | $30K | Medicare/Medicaid |
| TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC | $30K | Pharmacy |
| TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION | $30K | Pharmacy |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY | $30K | Pharmacy |
| TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA | $30K | Medicare/Medicaid |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. | $30K | Pharmacy |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS | $30K | Pharmacy |
| TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS | $30K | Medicare/Medicaid |
| TIBER CREEK GROUP OBO ABBVIE INC. | $20K | Medicare/Medicaid |
| VANTIVE US HEALTHCARE LLC | $10K | Health Issues |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC | $0 | |
| TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE | $0 |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.74M | 21 |
| 2025 | $1.74M | 18 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.